1. Yang, Zhengzheng, Li, Haiming, Dong, Tongjing, Cheng, Peiyu, Wang, Xiaomin. 2023. Comprehensive analysis of resistance mechanisms to EGFR-TKIs and establishment and validation of prognostic model. In Journal of cancer research and clinical oncology, 149, 13773-13792. doi:10.1007/s00432-023-05129-8. https://pubmed.ncbi.nlm.nih.gov/37532906/
2. Ren, Shiqi, Wang, Wei, Zhang, Chenlin, Lu, Bing, Yao, Lanlan. 2021. The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma. In Cancer medicine, 10, 3403-3412. doi:10.1002/cam4.3877. https://pubmed.ncbi.nlm.nih.gov/33934535/
3. Li, Kai-Min, Meng, Li-Fei, Yang, Zhi-Hao, Hu, Wen-Tao. 2024. NUP155 and NDC1 interaction in NSCLC: a promising target for tumor progression. In Frontiers in pharmacology, 15, 1514367. doi:10.3389/fphar.2024.1514367. https://pubmed.ncbi.nlm.nih.gov/39720592/
4. Zhi, Shuang, Jiang, Bengui, Yu, Wenying, Zhou, Teng, Li, Nan. 2022. Identification of candidate miRNA biomarkers correlated with the prognosis of cell carcinoma and endocervical adenocarcinoma via integrated bioinformatics analysis. In American journal of translational research, 14, 8146-8155. doi:. https://pubmed.ncbi.nlm.nih.gov/36505295/
智鼠故事 
